{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:46:06Z","timestamp":1761630366715},"reference-count":70,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,4,1]]},"DOI":"10.1210\/en.2004-0734","type":"journal-article","created":{"date-parts":[[2004,12,30]],"date-time":"2004-12-30T03:38:46Z","timestamp":1104377926000},"page":"1843-1853","source":"Crossref","is-referenced-by-count":21,"title":["Do Cyclooxygenase-2 Knockout Mice Have Primary Hyperparathyroidism?"],"prefix":"10.1210","volume":"146","author":[{"given":"Manshan","family":"Xu","sequence":"first","affiliation":[{"name":"Departments of Medicine (M.X., S.C., L.R., C.P.), University of Connecticut Health Center, Farmington, Connecticut 06030"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilpa","family":"Choudhary","sequence":"additional","affiliation":[{"name":"Departments of Medicine (M.X., S.C., L.R., C.P.), University of Connecticut Health Center, Farmington, Connecticut 06030"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Goltzman","sequence":"additional","affiliation":[{"name":"Department of Medicine, McGill University Health Center and McGill University (D.G.), Montre\u0301al, Canada 3A 1A1"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felicia","family":"Ledgard","sequence":"additional","affiliation":[{"name":"Orthopedics (F.L., D.A., G.G., B.K.-J.), University of Connecticut Health Center, Farmington, Connecticut 06030"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Adams","sequence":"additional","affiliation":[{"name":"Orthopedics (F.L., D.A., G.G., B.K.-J.), University of Connecticut Health Center, Farmington, Connecticut 06030"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Gronowicz","sequence":"additional","affiliation":[{"name":"Orthopedics (F.L., D.A., G.G., B.K.-J.), University of Connecticut Health Center, Farmington, Connecticut 06030"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boguslawa","family":"Koczon-Jaremko","sequence":"additional","affiliation":[{"name":"Orthopedics (F.L., D.A., G.G., B.K.-J.), University of Connecticut Health Center, Farmington, Connecticut 06030"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Raisz","sequence":"additional","affiliation":[{"name":"Departments of Medicine (M.X., S.C., L.R., C.P.), University of Connecticut Health Center, Farmington, Connecticut 06030"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Pilbeam","sequence":"additional","affiliation":[{"name":"Departments of Medicine (M.X., S.C., L.R., C.P.), University of Connecticut Health Center, Farmington, Connecticut 06030"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2019041200570094300_R1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-1-4899-1813-0_9","article-title":"Function and regulation of prostaglandin synthase-2","volume":"407","author":"Herschman","year":"1997","journal-title":"Adv Exp Med Biol"},{"key":"2019041200570094300_R2","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1172\/JCI13271","article-title":"Why there are two cyclooxygenase isozymes","volume":"107","author":"Smith","year":"2001","journal-title":"J Clin Invest"},{"key":"2019041200570094300_R3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","article-title":"Cyclooxygenases: structural, cellular, and molecular biology","volume":"69","author":"Smith","year":"2000","journal-title":"Annu Rev Biochem"},{"key":"2019041200570094300_R4","first-page":"979","article-title":"Prostaglandins and bone metabolism","author":"Pilbeam","year":"2002"},{"key":"2019041200570094300_R5","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1172\/JCI8195","article-title":"Prostaglandin G\/H synthase-2 is required for maximal formation of osteoclast-like cells in culture","volume":"105","author":"Okada","year":"2000","journal-title":"J Clin Invest"},{"key":"2019041200570094300_R6","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1359\/jbmr.2002.17.8.1430","article-title":"Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfal binding site: role in effects of bone morphogenetic protein 2 in vitro and in vivo","volume":"17","author":"Chikazu","year":"2002","journal-title":"J Bone Miner Res"},{"key":"2019041200570094300_R7","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1359\/jbmr.2003.18.10.1813","article-title":"Extracellular calcium is a potent inducer of cyclo-oxygenase-2 in murine osteoblasts through an ERK signaling pathway","volume":"18","author":"Choudhary","year":"2003","journal-title":"J Bone Miner Res"},{"key":"2019041200570094300_R8","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1210\/endo.135.3.8070358","article-title":"Regulation of the two prostaglandin G\/H synthases by parathyroid hormone, interleukin-1, cortisol and prostaglandin E2 in cultured neonatal mouse calvariae","volume":"135","author":"Kawaguchi","year":"1994","journal-title":"Endocrinology"},{"key":"2019041200570094300_R9","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1359\/jbmr.1998.13.7.1066","article-title":"Regulation of prostaglandin G\/H synthase-2 expression by interleukin-1 in human osteoblast-like cells","volume":"13","author":"Min","year":"1998","journal-title":"J Bone Miner Res"},{"key":"2019041200570094300_R10","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1359\/jbmr.2000.15.6.1138","article-title":"Involvement of C\/EBP transcription factors in prostaglandin G\/H synthase-2 gene induction by interleukin-1 in osteoblastic MC3T3\u2013E1 cells","volume":"15","author":"Harrison","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2019041200570094300_R11","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/jbmr.5650110309","article-title":"Interleukin-4 inhibits prostaglandin G\/H synthase-2 and cytosolic phospholipase A2 induction in neonatal mouse parietal bone cultures","volume":"11","author":"Kawaguchi","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2019041200570094300_R12","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1210\/endo.138.6.5192","article-title":"Transcriptional induction of cyclooxygenase-2 in osteoblasts is involved in interleukin-6-induced osteoclast formation","volume":"138","author":"Tai","year":"1997","journal-title":"Endocrinology"},{"key":"2019041200570094300_R13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/jbmr.5650090607","article-title":"Stimulation of prostaglandin E2 production by interleukin-1 and transforming growth factor-\u03b1 in osteoblastic MC3T3\u2013E1 cells","volume":"9","author":"Harrison","year":"1994","journal-title":"J Bone Miner Res"},{"key":"2019041200570094300_R14","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1210\/endo.138.11.5495","article-title":"Transforming growth factor-\u03b21 regulation of prostaglandin G\/H syntase-2 expression in osteoblastic MC3T3\u2013E1 cells","volume":"138","author":"Pilbeam","year":"1997","journal-title":"Endocrinology"},{"key":"2019041200570094300_R15","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1172\/JCI118140","article-title":"Regulation of inducible prostaglandin G\/H synthase mRNA levels and promoter activity by basic fibroblast growth factor in osteoblastic cells","volume":"96","author":"Kawaguchi","year":"1995","journal-title":"J Clin Invest"},{"key":"2019041200570094300_R16","doi-asserted-by":"crossref","first-page":"25643","DOI":"10.1016\/S0021-9258(19)74438-X","article-title":"Differential regulation of inducible and constitutive prostaglandin endoperoxide synthase in osteoblastic MC3T3\u2013E1 cells","volume":"268","author":"Pilbeam","year":"1993","journal-title":"J Biol Chem"},{"key":"2019041200570094300_R17","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1210\/endo.138.9.5391","article-title":"Parathyroid hormone increases prostaglandin G\/H synthase-2 transcription by a cyclic adenosine 3\u2032,5\u2032-monophosphate-mediated pathway in murine osteoblastic MC3T3\u2013E1 cells","volume":"138","author":"Tetradis","year":"1997","journal-title":"Endocrinology"},{"key":"2019041200570094300_R18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1359\/jbmr.1997.12.1.45","article-title":"Pulsating fluid flow stimulates prostaglandin release and inducible prostaglandin G\/H synthase mRNA expression in primary mouse bone cells","volume":"12","author":"Klein-Nulend","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2019041200570094300_R19","doi-asserted-by":"crossref","first-page":"C1591","DOI":"10.1152\/ajpcell.1998.275.6.C1591","article-title":"Fluid shear-induced mechanical signaling in MC3T3\u2013E1 osteoblasts requires cytoskeleton-integrin interactions","volume":"275","author":"Pavalko","year":"1998","journal-title":"Am J Physiol"},{"key":"2019041200570094300_R20","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1359\/jbmr.2002.17.2.266","article-title":"Fluid flow induction of cyclo-oxygenase 2 gene expression in osteoblasts is dependent on an extracellular signal-regulated kinase signaling pathway","volume":"17","author":"Wadhwa","year":"2002","journal-title":"J Bone Miner Res"},{"key":"2019041200570094300_R21","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/jbmr.5650100311","article-title":"Autoregulation of inducible prostaglandin G\/H synthase in osteoblastic cells by prostaglandins","volume":"10","author":"Pilbeam","year":"1994","journal-title":"J Bone Miner Res"},{"key":"2019041200570094300_R22","first-page":"S45","article-title":"Knockout of cyclooxygenase-2 (COX-2) in mice results in a skeletal phenotype but does not influence mechanical responsiveness","volume":"18","author":"Alam","year":"2003","journal-title":"J Bone Miner Res"},{"key":"2019041200570094300_R23","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00223-002-0009-x","article-title":"Congenital lack of COX-2 affects mechanical and geometric properties of bone in mice","volume":"73","author":"Chen","year":"2003","journal-title":"Calcif Tissue Int"},{"key":"2019041200570094300_R24","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/378406a0","article-title":"Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II","volume":"378","author":"Dinchuk","year":"1995","journal-title":"Nature"},{"key":"2019041200570094300_R25","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0092-8674(95)90125-6","article-title":"Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse","volume":"83","author":"Morham","year":"1995","journal-title":"Cell"},{"key":"2019041200570094300_R26","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1046\/j.1523-1755.2000.00413.x","article-title":"Postnatal development and progression of renal dysplasia in cyclooxygenase-2 null mice","volume":"58","author":"Norwood","year":"2000","journal-title":"Kidney Int"},{"key":"2019041200570094300_R27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0092-8674(00)80402-X","article-title":"Multiple female reproductive failures in cyclooxygenase 2-deficient mice","volume":"91","author":"Lim","year":"1997","journal-title":"Cell"},{"key":"2019041200570094300_R28","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"Parfitt","year":"1987","journal-title":"J Bone Miner Res"},{"key":"2019041200570094300_R29","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/jbmr.5650051010","article-title":"Frequency distributions of tetracycline-based measurements: Implications for the interpretation of bone formation indices in the absence of double-labeled surfaces","volume":"5","author":"Folders","year":"1990","journal-title":"J Bone Miner Res"},{"key":"2019041200570094300_R30","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1073\/pnas.98.3.1059","article-title":"Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2","volume":"98","author":"Loftin","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041200570094300_R31","doi-asserted-by":"crossref","first-page":"19891","DOI":"10.1074\/jbc.272.32.19891","article-title":"Prostaglandin E2 amplifies cytosolic phospholipase A2- and cyclooxygenase-2-dependent delayed prostaglandin E2 generation in mouse osteoblastic cells. Enhancement by secretory phospholipase A2","volume":"272","author":"Murakami","year":"1997","journal-title":"J Biol Chem"},{"key":"2019041200570094300_R32","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s004670000355","article-title":"Molecular mechanisms of secondary hyperparathyroidism","volume":"14","author":"Silver","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"2019041200570094300_R33","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1053\/ajkd.2001.20740","article-title":"Role of phosphorus in the pathogenesis of secondary hyperparathyroidism","volume":"37","author":"Slatopolsky","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"2019041200570094300_R34","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00041552-200207000-00005","article-title":"Signal transduction in the parathyroid","volume":"11","author":"Kifor","year":"2002","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2019041200570094300_R35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.1523-1755.61.s80.26.x","article-title":"Pathogenesis of refractory secondary hyperparathyroidism","volume":"80","author":"Rodriguez","year":"2002","journal-title":"Kidney Int"},{"key":"2019041200570094300_R36","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2460\/ajvr.2003.64.1161","article-title":"Serum concentrations of 1,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol in clinically normal dogs and dogs with acute and chronic renal failure","volume":"64","author":"Gerber","year":"2003","journal-title":"Am J Vet Res"},{"key":"2019041200570094300_R37","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S8756-3282(99)00263-X","article-title":"Daily intermittent decreases in serum levels of parathyroid hormone have an anabolic-like action on the bones of uremic rats with low-turnover bone and osteomalacia","volume":"26","author":"Ishii","year":"2000","journal-title":"Bone"},{"key":"2019041200570094300_R38","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1681\/ASN.V115903","article-title":"Activation of the calcium receptor by a calcimimetic compound halts the progression of secondary hyperparathyroidism in uremic rats","volume":"11","author":"Chin","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"2019041200570094300_R39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/ki.1996.283","article-title":"1,25-Dihydroxyvitamin D3 and 22-oxacalcitriol prevent the decrease in vitamin D receptor content in the parathyroid glands of uremic rats","volume":"50","author":"Denda","year":"1996","journal-title":"Kidney Int:"},{"key":"2019041200570094300_R40","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1046\/j.1523-1755.2003.00029.x","article-title":"Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia","volume":"63","author":"Slatopolsky","year":"2003","journal-title":"Kidney Int"},{"key":"2019041200570094300_R41","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1210\/endo.140.5.6691","article-title":"Positive and negative regulations of the renal 25-hydroxyvitamin D3 1\u03b1-hydroxylase gene by parathyroid hormone, calcitonin, and 1\u03b1,25(OH)2D3 in intact animals","volume":"140","author":"Murayama","year":"1999","journal-title":"Endocrinology"},{"key":"2019041200570094300_R42","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/01.LAB.0000064703.92382.50","article-title":"Terminal renal failure in mice lacking transcription factor AP-2\u03b2","volume":"83","author":"Moser","year":"2003","journal-title":"Lab Invest"},{"key":"2019041200570094300_R43","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1210\/jc.2002-021404","article-title":"Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone","volume":"88","author":"Maruani","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041200570094300_R44","first-page":"N24","article-title":"The pathophysiology of primary hyperparathyroidism","volume":"17","author":"Brown","year":"2002","journal-title":"J Bone Miner Res"},{"key":"2019041200570094300_R45","first-page":"573","article-title":"Vitamin D gene regulation","author":"Christakos","year":"2002"},{"key":"2019041200570094300_R46","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0090-6980(84)90203-X","article-title":"Biphasic action of prostaglandin E2 on conversion of 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 in chick renal tubules","volume":"27","author":"Wark","year":"1984","journal-title":"Prostaglandins"},{"key":"2019041200570094300_R47","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1042\/bj2160237","article-title":"Stimulatory effect of prostaglandin E2 on 1\u03b1,25-dihydroxyvitamin D3 synthesis in rats","volume":"216","author":"Yamada","year":"1983","journal-title":"Biochem J"},{"key":"2019041200570094300_R48","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0952-3278(97)90541-X","article-title":"Parathormone, 1,25 dihydroxyvitamin D and prostaglandin E2 correlation in children with idiopathic hypercalciuria","volume":"56","author":"Hasanoglu","year":"1997","journal-title":"Prostaglandins Leukotrienes Essent Fatty Acids"},{"key":"2019041200570094300_R49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0090-6980(98)00073-2","article-title":"Prostaglandin E2 regulates vitamin D receptor expression, vitamin D-24-hydroxylase activity and cell proliferation in an adherent human myeloid leukemia cell line (Ad-HL60)","volume":"57","author":"Smith","year":"1999","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"2019041200570094300_R50","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI10523","article-title":"Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice","volume":"107","author":"Imanishi","year":"2001","journal-title":"J Clin Invest"},{"key":"2019041200570094300_R51","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1046\/j.1523-1755.2002.00258.x","article-title":"Treatment of a murine model of high-turnover renal osteodystrophy by exogenous BMP-7","volume":"61","author":"Gonzalez","year":"2002","journal-title":"Kidney Int"},{"key":"2019041200570094300_R52","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S8756-3282(03)00023-1","article-title":"Correction of the abnormal mineral ion homeostasis with a high-calcium, high-phosphorus, high-lactose diet rescues the PDDR phenotype of mice deficient for the 25-hydroxyvitamin D-1\u03b1-hydroxylase (CYP27B1)","volume":"32","author":"Dardenne","year":"2003","journal-title":"Bone"},{"key":"2019041200570094300_R53","doi-asserted-by":"crossref","first-page":"9733","DOI":"10.1073\/pnas.1633774100","article-title":"Regulation of the murine renal vitamin D receptor by 1,25-dihydroxyvitamin D3 and calcium","volume":"100","author":"Healy","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041200570094300_R54","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1210\/en.2003-1097","article-title":"Skeletal abnormalities in Pth-null mice are influenced by dietary calcium","volume":"145","author":"Miao","year":"2004","journal-title":"Endocrinology"},{"key":"2019041200570094300_R55","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1530\/eje.0.1480597","article-title":"Influence of renal function on clinico-pathological features of primary hyperparathyroidism","volume":"148","author":"Yamashita","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"2019041200570094300_R56","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0090-6980(85)90149-2","article-title":"Production of prostaglandins by dispersed cells and fragments from bovine parathyroid glands","volume":"29","author":"Brown","year":"1985","journal-title":"Prostaglandins"},{"key":"2019041200570094300_R57","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1210\/endo-109-5-1545","article-title":"Effects of prostaglandins on adenosine 3\u2032,5\u2032-monophosphate content and adenylate cyclase activity in dispersed bovine parathyroid cells","volume":"109","author":"Gardner","year":"1981","journal-title":"Endocrinology"},{"key":"2019041200570094300_R58","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1172\/JCI119725","article-title":"Hypercalcemia stimulates expression of intrarenal phospholipase A2 and prostaglandin H synthase-2 in rats. Role of angiotensin II AT1 receptors","volume":"100","author":"Mangat","year":"1997","journal-title":"J Clin Invest"},{"key":"2019041200570094300_R59","doi-asserted-by":"crossref","first-page":"15192","DOI":"10.1074\/jbc.273.24.15192","article-title":"Co-expression of a Ca2+-inhibitable adenylyl cyclase and of a Ca2+-sensing receptor in the cortical thick ascending limb cell of the rat kidney. Inhibition of hormone-dependent cAMP accumulation by extracellular Ca2+","volume":"273","author":"Jesus Ferreira","year":"1998","journal-title":"J Biol Chem"},{"key":"2019041200570094300_R60","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S8756-3282(97)00147-6","article-title":"The in vivo anabolic actions of prostaglandins in bone","volume":"21","author":"Jee","year":"1997","journal-title":"Bone"},{"key":"2019041200570094300_R61","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1677\/joe.0.1560051","article-title":"Differential effects of systemic prostaglandin E2 on bone mass in rat long bones and calvariae","volume":"156","author":"Suponitzky","year":"1998","journal-title":"J Endocrinol"},{"key":"2019041200570094300_R62","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1210\/endo.130.1.1309342","article-title":"Stimulation of bone nodule formation in vitro by prostaglandins E1 and E2","volume":"130","author":"Flanagan","year":"1992","journal-title":"Endocrinology"},{"key":"2019041200570094300_R63","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S8756-3282(97)00033-1","article-title":"Systemic administration of an anabolic dose of PGE2 in young rats increases the osteogenic capacity of bone marrow","volume":"20","author":"Weinreb","year":"1997","journal-title":"Bone"},{"key":"2019041200570094300_R64","first-page":"S217","article-title":"Effects of cyclooxygenase-2 gene disruption on osteoblastic function","volume":"15","author":"Okada","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2019041200570094300_R65","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1172\/JCI0215681","article-title":"Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair","volume":"109","author":"Zhang","year":"2002","journal-title":"J Clin Invest"},{"key":"2019041200570094300_R66","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1359\/jbmr.2003.18.10.1795","article-title":"Association between bone mineral density and the use of nonsteroidal anti-inflammatory drugs and aspirin: impact of cyclooxygenase selectivity","volume":"18","author":"Carbone","year":"2003","journal-title":"J Bone Miner Res"},{"key":"2019041200570094300_R67","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.1002\/jbmr.5650071403","article-title":"Control of bone architecture by functional load bearing","volume":"7","author":"Lanyon","year":"1992","journal-title":"J Bone Miner Res"},{"key":"2019041200570094300_R68","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1359\/jbmr.2002.17.6.977","article-title":"Do inhibitors of cyclooxygenase-2 impair bone healing?","volume":"17","author":"Einhorn","year":"2002","journal-title":"J Bone Miner Res"},{"key":"2019041200570094300_R69","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1359\/jbmr.2002.17.6.963","article-title":"Cyclo-oxygenase 2 function is essential for bone fracture healing","volume":"17","author":"Simon","year":"2002","journal-title":"J Bone Miner Res"},{"key":"2019041200570094300_R70","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1084\/jem.187.4.517","article-title":"Compensatory prostaglandin E2 biosynthesis in cyclooxygenase 1 or 2 null cells","volume":"187","author":"Kirtikara","year":"1998","journal-title":"J Exp Med"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/146\/4\/1843\/10900041\/endo1843.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T02:06:41Z","timestamp":1625278001000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/146\/4\/1843\/2878326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,1]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2004-0734","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,1]]}}}